A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01011998
Recruitment Status : Withdrawn (Withdrawn due to lack of accrual per Center DSMP, with PI concurrence)
First Posted : November 11, 2009
Last Update Posted : September 27, 2011
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : June 2010
  Study Completion Date : July 2010